13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q2 2023. See the latest, Q2 2026 →
Reported value
$920.27B
+12% on the quarter before
Positions
6,885
780 new · 842 sold out
Top 10
19.6%
of the value
Est. gain
+$46.87B
on stocks held all quarter
Est. return
+6.4%
on those stocks since Q1 2023
Positions as of Jun 30, 2023, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 30% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2023. Striped tiles are options.
Largest buys
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$6.27BAdded · 3.3% → 4.2%+18,407,096 shares
- Vanguard 500 Index Fund~$5.61BAdded · 0.4% → 1.0%+13,769,409 shares
- SPDR S&P 500 ETF Trust~$3.32BAdded · 2.6% → 2.9%+7,481,097 shares
- Meta~$3.21BAdded · 0.8% → 1.4%+11,196,519 shares
- Apple~$2.90BAdded · 2.7% → 3.2%+14,926,191 shares
- Nvidia~$2.32BAdded · 1.0% → 1.6%+5,483,030 shares
- Alphabet~$1.78BAdded · 0.9% → 1.1%+14,746,989 shares
- Vanguard Short-Term Treasury Index Fund~$1.55BAdded · 0.2% → 0.3%+26,855,553 shares
- Eli Lilly~$1.51BAdded · 0.5% → 0.7%+3,228,109 shares
- Broadcom~$1.46BAdded · 0.1% → 0.3%+1,685,799 shares
Largest sells
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$4.29BCut · 1.0% → 0.5%−9,683,800 underlying
- Ishares Short Treasury Bond~$3.23BCut · 0.4% → 0.0%−29,202,260 shares
- SPDR S&P 500 ETF TrCALL~$2.43BCut · 0.5% → 0.2%−5,480,700 underlying
- Jpmorgan Betabuilders Europe E~$1.76BCut · 1.0% → 0.7%−32,440,072 shares
- Schwab U.S. Tips ETF~$702.0MCut · 0.1% → 0.0%−13,390,123 shares
- Nike Inc~$702.0MCut · 0.3% → 0.2%−6,360,044 shares
- Tesla~$651.6MCut · 0.7% → 0.8%−2,489,185 shares
- Invesco Qqq TrCALL~$607.7MCut · 0.2% → 0.2%−1,645,100 underlying
- Truist Financial Corp~$591.7MCut · 0.2% → 0.1%−19,496,024 shares
- Boston Scientific Corp~$568.7MCut · 0.2% → 0.1%−10,514,440 shares
Holdings
As of Jun 30, 2023. Changes are in shares against Mar 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON · shares +19% · price +18.1% | 4.2% | $38.49B | +$4.94B | ||||||||
| AppleCOMMON · shares +11% · price +17.6% | 3.2% | $29.14B | +$3.93B | ||||||||
| SPDR S&P 500 ETF TrustFUND · shares +14% · price +8.3% | 2.9% | $26.45B | +$1.77B | ||||||||
| AmazonCOMMON · shares +0.04% · price +26.2% | 1.9% | $17.57B | +$3.65B | ||||||||
| NvidiaCOMMON · shares +18% · price +52.3% | 1.6% | $15.05B | +$4.37B | ||||||||
| MetaCOMMON · shares +34% · price +35.4% | 1.4% | $12.64B | +$2.46B | ||||||||
| Unitedhealth Group IncCOMMON · shares +13% · price +1.7% | 1.2% | $10.77B | +$159.9M | ||||||||
| AlphabetCOMMON · shares +21% · price +16.3% | 1.1% | $10.43B | +$1.21B | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +4.7% · price −0.1% | 1.1% | $10.36B | −$8.1M | ||||||||
| Vanguard 500 Index FundETF · shares +155% · price +8.3% | 1.0% | $9.22B | +$276.8M | ||||||||
| MastercardCOMMON · shares +13% · price +8.2% | 0.90% | $8.25B | +$554.8M | ||||||||
| Vanguard Total Bond MarketFUND · shares +7.0% · price −1.5% | 0.83% | $7.68B | −$112.6M | ||||||||
| Abbvie IncCOMMON · shares −1.9% · price −15.5% | 0.83% | $7.65B | −$1.40B | ||||||||
| TeslaCOMMON · shares −8.5% · price +26.2% | 0.76% | $7.00B | +$1.45B | ||||||||
| Eli LillyCOMMON · shares +30% · price +36.6% | 0.72% | $6.63B | +$1.37B | ||||||||
| Bristol-Myers Squibb CoCOMMON · shares +6.9% · price −7.7% | 0.72% | $6.61B | −$517.8M | ||||||||
| Jpmorgan Betabuilders Europe EETF · shares −21% · price +1.4% | 0.72% | $6.58B | +$90.0M | ||||||||
| AlphabetCOMMON · shares +4.2% · price +15.4% | 0.70% | $6.45B | +$826.2M | ||||||||
| Jpmorgan Betabuilders Japan EtETF · shares +3.1% · price +6.5% | 0.69% | $6.32B | +$373.3M | ||||||||
| Exxon Mobil CorpCOMMON · shares +6.8% · price −2.2% | 0.65% | $6.00B | −$126.3M | ||||||||
| Nxp Semiconductors N VCOMMON · shares +8.2% · price +9.8% | 0.63% | $5.79B | +$476.1M | ||||||||
| ConocophillipsCOMMON · shares −7.1% · price +4.4% | 0.63% | $5.76B | +$244.6M | ||||||||
| Nextera Energy IncCOMMON · shares +3.8% · price −3.7% | 0.61% | $5.59B | −$209.0M | ||||||||
| Lowes Cos IncCOMMON · shares +11% · price +12.9% | 0.58% | $5.38B | +$551.3M | ||||||||
| Johnson & JohnsonCOMMON · shares +24% · price +6.8% | 0.57% | $5.26B | +$270.6M | ||||||||
| Total · 6,885 positions | 100% | $920.27B | +$46.87B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2023 to Q2 2023: 4,933 stocks held throughout, up $46.87B (+6.4%).
- Microsoft+$4.94B+18%
- Nvidia+$4.37B+52%
- Apple+$3.93B+18%
- Amazon+$3.65B+26%
- Meta+$2.46B+35%
- MercadoLibre−$297.5M−10%
- United Parcel Service Inc−$304.6M−8%
- Bristol-Myers Squibb Co−$517.8M−8%
- Regeneron Pharmaceuticals−$654.3M−13%
- Abbvie Inc−$1.40B−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 17 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |